Procedural Oxygen Mask vs. Nasal Cannula for Hypoxemia Prevention During Endoscopic Retrograde Cholangiopancreatography

This study aims to compare the efficacy of different oxygen delivery methods (Nasal Cannula [NC] and Procedural Oxygen Mask [POM]) in preventing the incidence of hypoxemia during Endoscopic Retrograde Cholangiopancreatography (ERCP). Designed as a randomized controlled prospective study, participants were assigned into two groups, Group N (NC) and Group P (POM), at a 1:1 ratio through randomization. The randomization was performed using computer-assisted random allocation; however, due to the visual differences in the oxygen delivery devices, neither healthcare providers nor patients could be blinded to the randomization results. A power analysis conducted to establish a statistical power of 80% and an alpha level of 0.05 indicated that a total of 140 patients, with 70 patients in each group, should be included in the study. Considering potential dropouts, 150 patients will be included in the study This evaluation ensures that an adequate sample size is obtained to detect a significant difference in the incidence of hypoxemia.

Throughout the ERCP procedure, all patients will be monitored using pulse oximetry, electrocardiography (ECG), and non-invasive blood pressure monitoring. Capnography will be applied in both groups, and necessary interventions will be carried out by anesthesia specialists if a patient's oxygen saturation falls below 90%. All interventions and events will be meticulously documented. Following the procedure, patients will be monitored in the post-anesthesia care unit (PACU), and those with a Post-Anesthesia Discharge Scoring System (PADSS) score of 9 or higher will be discharged.

Anesthesia Management The oxygen flow rate will be maintained constant throughout the procedure. Initially, patients will receive midazolam at a dose of 0.02 mg/kg, followed by 0.3 mg/kg of ketamine. To ensure sedation, propofol will be administered as an initial bolus dose of 0.5-1.0 mg/kg; further bolus doses of 0.25-0.5 mg/kg will be given every 1-3 minutes to maintain the desired sedation level. The target sedation level will be aimed at 3-4 on the Ramsay Sedation Scale (RSS), and these target values will be preserved during the procedure. Upon completion of the procedure, patients will be awakened using verbal and tactile stimuli; once the RSS reaches 2, they will be transferred to the PACU. In the PACU, patients will be discharged if they achieve a PADSS score of 9 or above.

Oxygen Reserve Index (ORi) measurement will performed on all patients. The ORi value will measured and recorded at the plateau level during the preoxygenation stage (as the baseline), immediately after the start of the procedure, at the end of the procedure, and the highest ORi value measured throughout the procedure

Vital signs, procedure durations, and dosages of medications used for each patient will be meticulously recorded. All anesthesia-related decisions during the procedure will be made by the supervising anesthesia specialist.

Inclusion criteria

• Aged 18-75 years
• American Society of Anesthesiologists (ASA) classification of 1-2-3
• Patients scheduled for ERCP at Kocaeli City Hospital Endoscopy Unit

Exclusion criteria

• Patients who refuse to participate in the study
• Patients with allergies to ketamine, propofol, or midazolam
• Patients diagnosed with psychiatric disorders
• Patients with a body mass index (BMI) >30 kg/m²
• Patients with cognitive impairment, dementia, or communication issues
• Pregnant patients or those in the postpartum period
• Patients diagnosed with sleep apnea syndrome
• History of intubation within the last 3 months
• History of lower respiratory tract infection within the last 3 months
• History of intensive care unit admission within the last 3 months
• Patients with a tracheostomy
• Patients with a history of tracheostomy
• Patients who are oxygen-dependent due to a medical condition
• Patients with lung cancer or who have undergone surgery on their lungs
• Patients with asthma, COPD, or interstitial lung diseases
• Patients with uncontrolled hypertension (BP >180/110)
• Patients receiving home care